Clinical Trials · NCT07426055
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Affidea Nu-med Center of Oncological DIagnostics and Therapy
- Enrollment
- 1,200
- Start date
- Mar 2026
- Locations
- 1 site, Poland
- Primary endpoint
- Failure-Free Survival (FFS)